In her presentation, Dr. Emily Conant from the University of Pennsylvania talked about opportunities for DBT with help from AI, including improvements in accuracy and efficiency, decreasing variability in image interpretation, and better assessing breast cancer risk.

“I want you just to remember and always think about our patients,” Conant said. “What we’re really looking for is to improve outcomes for them.”

DBT has been available in U.S. markets for 10 years and has been touted by researchers for its higher accuracy over conventional mammography. AI-related research meanwhile has…